Clinical Trials
Friday, July 25th, 2014
PLOS: July 18, 2014 Small clinical trials have reported that low-frequency repetitive transcranial magnetic stimulation (rTMS) might improve language recovery in patients with aphasia after stroke. However, no systematic reviews or meta-analyses studies have investigated the effect of rTMS on aphasia. The objective of this study was to perform a meta-analysis of studies that explored […]
Clinical Trials
Friday, July 25th, 2014
Am J Clin Nutr: July 2, 2014 Background: MicroRNAs have emerged as important epigenetic regulators in cardiovascular diseases (CVDs). Using an observational meta-analysis design, we previously characterized a gain-of-function microRNA-410 target site polymorphism (rs13702T>C) in the 3′untranslated region of the lipoprotein lipase (LPL) gene. The Callele was associated with lower triglycerides, and this association was modulated by fat […]
Clinical Trials
Friday, July 25th, 2014
JACC: July 2014 The PREVAIL (Watchman LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy) trial is the latest in the series of studies evaluating left atrial appendage (LAA) occlusion with the Watchman device (Boston Scientific, Natick, Massachusetts) as an alternative to warfarin therapy for the prevention of stroke in patients with nonvalvular […]
Clinical Trials
Friday, July 25th, 2014
JACC: July 2014 Background In the PROTECT AF (Watchman Left Atrial Appendage Closure Technology for Embolic Protection in Patients With Atrial Fibrillation) trial that evaluated patients with nonvalvular atrial fibrillation (NVAF), left atrial appendage (LAA) occlusion was noninferior to warfarin for stroke prevention, but a periprocedural safety hazard was identified. Read More
Clinical Trials
Friday, July 25th, 2014
International Journal of Stroke: 7 JUL 2014 Background Tablets are a novel line of computers controlled by a multitouch screen. Fine motor movements are captured on the tablet computer through electrical fields and can be qualitatively and quantitatively assessed. Evidence is limited on tablet use for stroke rehabilitation. Read More
Clinical Trials
Friday, July 25th, 2014
Heartrhythmjournal: June 21, 2014 Background Catheter ablation of atrial fibrillation (AF) is a physically demanding procedure for the operator, involving radiation exposure, and has limited success rates. Remote robotic navigation (RRN) may offer benefit to the procedure, though only one previous small randomized trial has assessed this. Objective Study the impact of RRN on one year […]
Clinical Trials
Friday, July 25th, 2014
CIRCULATIONAHA: May 2014 Background—Meaningful delays occurred in the Interventional Management of Stroke (IMS) III trial. Analysis of the work flow will identify factors contributing to the in-hospital delays. Methods and Results—In the endovascular arm of the IMS III trial, the following time intervals were calculated: stroke onset to emergency department arrival; emergency department to computed tomography […]
Clinical Trials
Saturday, July 5th, 2014
STROKEAHA: June 24, 2014 Background and Purpose—Behavioral measures are often used to distinguish subgroups of patients with stroke (eg, to predict treatment gains, stratify clinical trial enrollees, or select rehabilitation therapy). In studies of the upper extremity, measures of brain function using functional magnetic resonance imaging (fMRI) have also been found useful, but this approach […]
Clinical Trials
Saturday, July 5th, 2014
STROKEAHA: June 24, 2014 Background and Purpose—Thromboxane prostaglandin receptors have been implicated to be involved in the atherosclerotic process. We assessed whether Terutroban, a thromboxane prostaglandin receptor antagonist, affects the progression of atherosclerosis, as measured by common carotid intima-media thickness and carotid plaques. Methods—A substudy was performed among 1141 participants of the aspirin-controlled Prevention of Cerebrovascular […]
Clinical Trials
Saturday, July 5th, 2014
JAMA Intern Med.: June 16, 2014 Importance Significant variations in dose requirements of warfarin and its analogues (acenocoumarol and phenprocoumon) make selecting the appropriate dose for an individual patient difficult. Genetic factors account for approximately one-third of the variation in dose requirement. The clinical usefulness of genotype-guided dosing of warfarin has been previously assessed in randomized […]
